semaglutide vomiting bile Comparative safety and side effects of and tirzepatide: Implications for clinical decision-making in obesity management Semaglutide Side Effects: Short-Term vs.

Description

An overview table of included studies is available in the Supplementary Material (S1) and online with options to filter the database ( The table includes information on first author and year of publication (1), paper title (2), whether the study was included in the meta-analysis (3) or systematic review (4), a tag indicating whether ghrelin or GLP-1 was investigated (5), specification of the hormonal assessment and/or manipulation (i.e., whether plasma acyl-, desacyl-, total ghrelin, GLP-1 was measured, which substance was administered (if any)) (6), type of reward phase assessed during fMRI (7), type of reward (e.g., food, money, alcohol) (8), and sample population(s) (9)

It mainly targets postprandial glucose

In recent years, significant advances have been made in the pharmaceutical field for treating obesity, particularly through Novo Nordisks development of the GLP-1 receptor agonist semaglutide , which has had a major impact and revolutionized treatment

Nevertheless, Mounjaro is exclusively for type 2 diabetes management, while Zepbound is designed for chronic weight management for those with conditions like obesity or type 2 diabetes